{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:14:17Z","timestamp":1771024457270,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jconrel.2010.09.016","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T08:36:04Z","timestamp":1285230964000},"page":"380-387","source":"Crossref","is-referenced-by-count":27,"title":["Uptake of synthetic Low Density Lipoprotein by leukemic stem cells \u2014 a potential stem cell targeted drug delivery strategy"],"prefix":"10.1016","volume":"148","author":[{"given":"Peixun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Hatziieremia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moira A.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Scobie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Crossan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison M.","family":"Michie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessa L.","family":"Holyoake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin W.","family":"Halbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather G.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2010.09.016_bb0005","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMoa030513","article-title":"Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia","volume":"349","author":"Hughes","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0010","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0015","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0025","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0030","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.leu.2404893","article-title":"CD34+\/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate","volume":"22","author":"Bocchia","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","article-title":"Leucemies, Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years","volume":"109","author":"Rousselot","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0040","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0045","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/sj.leu.2404189","article-title":"BCR-ABL activity and its response to drugs can be determined in CD34(+) CML stem cells by CrkL phosphorylation status using flow cytometry","volume":"20","author":"Hamilton","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.exphem.2008.11.005","article-title":"Optimization of methods for the detection of BCR-ABL activity in Philadelphia-positive cells","volume":"37","author":"Hamilton","year":"2009","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0055","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.exphem.2009.02.006","article-title":"Inhibition of MDR1 does not sensitize primitive chronic myeloid leukemia CD34(+) cells to imatinib","volume":"37","author":"Hatziieremia","year":"2009","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0060","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0021-9258(17)32781-3","article-title":"Structure and interactions in human plasma Low Density Lipoprotein","volume":"252","author":"Deckelbaum","year":"1977","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/anie.198605833","article-title":"A receptor-mediated pathway for cholesterol homeostasis (Nobel lecture)","volume":"25","author":"Brown","year":"1986","journal-title":"Angewandte Chemie International Edition in English"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0070","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0002-9378(81)90952-2","article-title":"Low density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms","volume":"139","author":"Gal","year":"1981","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0075","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood.V63.5.1186.1186","article-title":"Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation","volume":"63","author":"Vitols","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cca.2005.10.022","article-title":"Alteration in lipid profile in patients of chronic myelold leukemia before and after chemotherapy","volume":"366","author":"Ghalaut","year":"2006","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0085","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/S0006-2952(02)01018-3","article-title":"Elevated uptake of low density lipoprotein by drug resistant human leukemic cell lines","volume":"63","author":"Tatidis","year":"2002","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0090","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/bp050043p","article-title":"Synthetic low-density lipoprotein, a novel biomimetic lipid supplement for serum-free tissue culture","volume":"21","author":"Hayavi","year":"2005","journal-title":"Biotechnology Progress"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0095","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1211\/jpp.58.10.0006","article-title":"Receptor dependent cellular uptake of synthetic low density lipoprotein by mammalian cells in serum-free tissue culture","volume":"58","author":"Hayavi","year":"2006","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-5173(01)00818-3","article-title":"Physicochemical properties of microemulsion analogues of low density lipoprotein containing amphiphatic apoprotein B receptor sequences","volume":"228","author":"Owens","year":"2001","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-2275(20)30188-7","article-title":"A synthetic low density lipoprotein particle capable of supporting U937 proliferation in vitro","volume":"43","author":"Baillie","year":"2002","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0378-5173(84)90096-6","article-title":"The incorporation of lipid-soluble antineoplastic agents into microemulsions protein-free analogs of low-density lipoprotein","volume":"21","author":"Halbert","year":"1984","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2006.07.046","article-title":"Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme","volume":"328","author":"Nikanjam","year":"2007","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/bc00026a002","article-title":"Low-density-lipoprotein as a vehicle for targeting antitumor compounds to cancer-cells","volume":"5","author":"Firestone","year":"1994","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature04496","article-title":"Purification and unique properties of mammary epithelial stem cells","volume":"439","author":"Stingl","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbmt.2004.11.004","article-title":"Brain tumor stem cells","volume":"11","author":"Dirks","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0135","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","article-title":"Prospective identification of tumorigenic prostate cancer stem cells","volume":"65","author":"Collins","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0140","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.leu.2403785","article-title":"Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro","volume":"19","author":"Jorgensen","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0145","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1074\/jbc.M406309200","article-title":"Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane","volume":"280","author":"Kramer","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0150","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood-2006-11-057521","article-title":"Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34(+) CML cells","volume":"109","author":"Jorgensen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0155","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1182\/blood-2005-11-4687","article-title":"OCT-1-mediated influx is a key determinant of the intraceflular uptake of imatinib but not nilotinib, (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib","volume":"108","author":"White","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0160","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/blood-2007-06-093617","article-title":"Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity","volume":"110","author":"White","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0165","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2006-02-003145","article-title":"Functional ABCG2 is overexpressed on primary CML CD34(+) cells and is inhibited by imatinib mesylate","volume":"108","author":"Jordanides","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0170","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/leu.2009.166","article-title":"Nilotinib concentration in cell lines and primary CD34(+) chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters","volume":"23","author":"Davies","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"Weisberg","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0180","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1182\/blood.V52.6.1099.1099","article-title":"Low-density lioprotein (LDL) receptor activity in human acute myelogenous leukaemia cells","volume":"52","author":"Ho","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2007.09.007","article-title":"Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme","volume":"124","author":"Nikanjam","year":"2007","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0190","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jconrel.2010.09.016_bb0195","first-page":"3426","article-title":"P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation","volume":"56","author":"WilsonRawls","year":"1996","journal-title":"Cancer Research"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365910007819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365910007819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T13:22:39Z","timestamp":1636550559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365910007819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0168365910007819"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2010.09.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}